192 related articles for article (PubMed ID: 19491034)
1. Novel polymeric film coatings for colon targeting: Drug release from coated pellets.
Karrout Y; Neut C; Wils D; Siepmann F; Deremaux L; Flament MP; Dubreuil L; Desreumaux P; Siepmann J
Eur J Pharm Sci; 2009 Jun; 37(3-4):427-33. PubMed ID: 19491034
[TBL] [Abstract][Full Text] [Related]
2. Enzymatically degraded Eurylon 6 HP-PG: ethylcellulose film coatings for colon targeting in inflammatory bowel disease patients.
Karrout Y; Neut C; Siepmann F; Wils D; Ravaux P; Deremaux L; Flament MP; Dubreuil L; Lemdani M; Desreumaux P; Siepmann J
J Pharm Pharmacol; 2010 Dec; 62(12):1676-84. PubMed ID: 21054393
[TBL] [Abstract][Full Text] [Related]
3. In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy.
Karrout Y; Dubuquoy L; Piveteau C; Siepmann F; Moussa E; Wils D; Beghyn T; Neut C; Flament MP; Guerin-Deremaux L; Dubreuil L; Deprez B; Desreumaux P; Siepmann J
J Control Release; 2015 Jan; 197():121-30. PubMed ID: 25445696
[TBL] [Abstract][Full Text] [Related]
4. Non-coated multiparticulate matrix systems for colon targeting.
Krenzlin S; Siepmann F; Wils D; Guerin-Deremaux L; Flament MP; Siepmann J
Drug Dev Ind Pharm; 2011 Oct; 37(10):1150-9. PubMed ID: 21417601
[TBL] [Abstract][Full Text] [Related]
5. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
[TBL] [Abstract][Full Text] [Related]
6. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
Bendas ER; Christensen JM; Ayres JW
Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of colon adhesive pellets of 5-aminosalicylic acid.
Xu M; Sun M; Qiao H; Ping Q; Elamin ES
Int J Pharm; 2014 Jul; 468(1-2):165-71. PubMed ID: 24746693
[TBL] [Abstract][Full Text] [Related]
8. Characterization of ethylcellulose: starch-based film coatings for colon targeting.
Karrout Y; Neut C; Wils D; Siepmann F; Deremaux L; Desreumaux P; Siepmann J
Drug Dev Ind Pharm; 2009 Oct; 35(10):1190-200. PubMed ID: 19555251
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the in-vivo drug release from pellets film-coated with a dispersion of high amylose starch and ethylcellulose for potential colon delivery.
Freire C; Podczeck F; Ferreira D; Veiga F; Sousa J; Pena A
J Pharm Pharmacol; 2010 Jan; 62(1):55-61. PubMed ID: 20722999
[TBL] [Abstract][Full Text] [Related]
10. Selective drug delivery to the colon using pectin-coated pellets.
He W; Qing D; Cao DY; Fan LF; Xiang B
PDA J Pharm Sci Technol; 2008; 62(4):264-72. PubMed ID: 19174955
[TBL] [Abstract][Full Text] [Related]
11. Novel polymeric film coatings for colon targeting: how to adjust desired membrane properties.
Karrout Y; Neut C; Wils D; Siepmann F; Deremaux L; Desreumaux P; Siepmann J
Int J Pharm; 2009 Apr; 371(1-2):64-70. PubMed ID: 19135511
[TBL] [Abstract][Full Text] [Related]
12. Novel mesalamine-loaded beads in tablets for delayed release of drug to the colon.
Nguyen C; Christensen JM; Ayres JW
Pharm Dev Technol; 2012; 17(1):73-83. PubMed ID: 20923254
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro evaluation of pH, time-based and enzyme-degradable pellets for colonic drug delivery.
Fude C; Lei Y; Jie J; Hongze P; Wenhui L; Dongmei C
Drug Dev Ind Pharm; 2007 Sep; 33(9):999-1007. PubMed ID: 17891587
[TBL] [Abstract][Full Text] [Related]
14. Exploiting gastrointestinal bacteria to target drugs to the colon: an in vitro study using amylose coated tablets.
Wilson PJ; Basit AW
Int J Pharm; 2005 Aug; 300(1-2):89-94. PubMed ID: 16023805
[TBL] [Abstract][Full Text] [Related]
15. Influence of the coating formulation on enzymatic digestibility and drug release from 5-aminosalicylic acid pellets coated with mixtures of high-amylose starch and Surelease intended for colon-specific drug delivery.
Freire C; Podczeck F; Veiga F; Sousa J
Drug Dev Ind Pharm; 2010 Feb; 36(2):161-72. PubMed ID: 19678749
[TBL] [Abstract][Full Text] [Related]
16. [Ulcerative colitis--colon delivery of 5-aminosalicylic acid].
Muraoka M; Kimura G; Zhaopeng H; Takada K
Nihon Rinsho; 1998 Mar; 56(3):788-94. PubMed ID: 9549374
[TBL] [Abstract][Full Text] [Related]
17. Colon targeting with bacteria-sensitive films adapted to the disease state.
Karrout Y; Neut C; Wils D; Siepmann F; Deremaux L; Dubreuil L; Desreumaux P; Siepmann J
Eur J Pharm Biopharm; 2009 Sep; 73(1):74-81. PubMed ID: 19406234
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease.
Patel MM; Amin AF
Pharm Dev Technol; 2013; 18(2):390-400. PubMed ID: 22304735
[TBL] [Abstract][Full Text] [Related]
19. Chitosan as a pore former in coated beads for colon specific drug delivery of 5-ASA.
Omwancha WS; Mallipeddi R; Valle BL; Neau SH
Int J Pharm; 2013 Jan; 441(1-2):343-51. PubMed ID: 23200955
[TBL] [Abstract][Full Text] [Related]
20. Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings.
Schellekens RC; Stellaard F; Mitrovic D; Stuurman FE; Kosterink JG; Frijlink HW
J Control Release; 2008 Dec; 132(2):91-8. PubMed ID: 18775755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
